Skip to main content
. Author manuscript; available in PMC: 2011 Mar 22.
Published in final edited form as: JPEN J Parenter Enteral Nutr. 2008 Jun 9;32(4):389–402. doi: 10.1177/0148607108317880

Table 5.

Microbiology of Nosocomial Infections

Pancreatic Necrosis Surgery
Nonpancreatic Surgery
STD-PN (n = 17) GLN-PN (n = 15) STD-PN (n = 12) GLN-PN (n = 15)
Fungal species 5 (3) 7 (4) 15 (6) 1 (1)a
Gram-positive bacteria
Staphylococcus aureus 5 (1) 1 (1) 8 (7) 1 (1)b
Staphylococcus species (coagulase negative) 4 (4) 8 (8) 3 (3) 3 (2)
Enterococcus species 1 (1) 2 (2) 1 (1) 1 (1)
Streptococcus species 0 1 (1) 0 1 (1)
Corynebacterium species 2 (2) 0 0 0
Gram-negative bacteria
Pseudomonas species 6 (5) 8 (4) 5 (5) 3 (3)
Klebsiella species 5 (4) 3 (2) 2 (2) 0
Stenotrophomonas maltophilia 0 0 3 (3) 0
Escherichia coli 0 2 (2) 1 (1) 2 (1)
Miscellaneous Gram-negative bacteria 5 (5) 2 (2) 2 (2) 2 (2)
Viral species 0 0 1 (1) 0

STD-PN, standard parenteral nutrition; GLN-PN, glutamine dipeptide-supplemented parenteral nutrition. Values are number of nosocomial infections due to microorganism (number of patients). Presumed causative microorganisms based on microbiological culture results.

a

P < .03

b

P < .01: GLN-PN vs STD-PN in the nonpancreatic surgery subgroup (Fisher exact test). Fungal species Breslow-Day interaction (P = .021), Staphylococcus aureus Breslow-Day interaction (P = .069). Other comparisons are not significant.

HHS Vulnerability Disclosure